NONLINEAR PHARMACOKINETICS OF 5-FLUOROURACIL AS DESCRIBED BY INVIVO BEHAVIOR OF 5,6 DIHYDRO-5-FLUOROURACIL

被引：24

作者：

DEBRUIJN, EA ^{[1
]}

REMEYER, L ^{[1
]}

TJADEN, UR ^{[1
]}

ERKELENS, C ^{[1
]}

DEBRAUW, LM ^{[1
]}

VANDEVELDE, CJH ^{[1
]}

机构：

[1] SYLVIUS LABS,DEPT CLIN ONCOL,2333 AL LEIDEN,NETHERLANDS

来源：

关键词：

D O I：

10.1016/0006-2952(86)90041-9

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：2461 / 2465

页数：5

共 16 条

[1] AUBERT C, 1981, B CANCER, V68, P343
[2] CHAUDHURI NK, 1958, CANCER RES, V18, P318
[3] CHAUDHURI NK, 1958, BIOCHEM PHARMACOL, V1, P328
[4] NON-LINEAR PHARMACOKINETIC MODELS FOR 5-FLUOROURACIL IN MAN - INTRAVENOUS AND INTRAPERITONEAL ROUTES
COLLINS, JM
DEDRICK, RL
KING, FG
SPEYER, JL
MYERS, CE
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) : 235 - 246
[5] DEBRUIJN EA, 1985, CANCER RES, V45, P5931
[6] A GAS-CHROMATOGRAPHIC ASSAY FOR THE DETERMINATION OF 5,6-DIHYDROFLUOROURACIL AND 5-FLUOROURACIL IN HUMAN-PLASMA
DEBRUIJN, EA
DRIESSEN, O
VANDENBOSCH, N
VANSTRIJEN, E
SLEE, PHTJ
VANOOSTEROM, AT
TJADEN, UR
[J]. JOURNAL OF CHROMATOGRAPHY, 1983, 278 (02): : 283 - 289
[7] DEBRUIN EA, 1983, J CHROMATOGR, V279, P603
[8] DIASIO RB, 1985, CANCER RES, V45, P4900
[9] HEIDELBERGER C, 1974, HDB EXPTL PHARMACO 2, V38, P193
[10] NON-LINEAR PHARMACOKINETICS FOR THE ELIMINATION OF 5-FLUOROURACIL AFTER INTRAVENOUS ADMINISTRATION IN CANCER-PATIENTS
MCDERMOTT, BJ
VANDENBERG, HW
MURPHY, RF
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 9 (03) : 173 - 178